A vial of Allergan Inc. Botox cosmetic and a syringe are arranged for a photograph at the offices of Marcus Facial Plastic Surgery in Redondo Beach, California, U.S., on Tuesday, April 22, 2014.
Bloomberg via Getty Images
By Amrutha Penumudi / Reuters
May 31, 2016

Billionaire investor Carl Icahn said on Tuesday he had acquired a “large position” in Botox-maker Allergan Plc ALLERGAN PLC


AGN
0.28%

and that he was very supportive of CEO Brent Saunders.

Shares of Allergan rose 2.6% to $242 in early trading.

Icahn, who did not disclose details of the stake, said he was confident in Saunders’ ability to enhance value for all Allergan shareholders.

Icahn, who launched a $150 million political action committee advocating tax reform to eliminate inversions, was firmly against the now terminated Pfizer-Allergan deal, saying it would result in the loss of the country’s 10th largest company to Ireland.

 

You May Like

EDIT POST